about
Treatment of medulloblastoma with a modified measles virusPreventing epidemics in a community of householdsImmunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responsesA 60-year review on the changing epidemiology of measles in capital Beijing, China, 1951-2011.Should measles be eradicated?Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.Thymic tolerance to only one viral protein reduces lymphocytic choriomeningitis virus-induced immunopathology and increases survival in perforin-deficient mice.Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage.Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer.Serological and virological characterization of clinically diagnosed cases of measles in suburban Khartoum.Oncolytic Viruses to Treat Ovarian Cancer Patients - a Review of Results From Clinical TrialsIdentification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides.Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer.A vectored measles virus induces hepatitis B surface antigen antibodies while protecting macaques against measles virus challenge.Priorities in global measles control: report of an outbreak in N'Djamena, Chad.Identifying high-risk areas for sporadic measles outbreaks: lessons from South Africa.[A survey on vaccine efficacy in the city of Bongor (Chad) and its operational consequences for the vaccination program]Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionalsA 'post-honeymoon' measles epidemic in Burundi: mathematical model-based analysis and implications for vaccination timingClinical testing of engineered oncolytic measles virus strains in the treatment of cancer: an overview.Engineered measles virus as a novel oncolytic therapy against prostate cancer.Therapeutic potential of oncolytic measles virus: promises and challenges.Use of attenuated paramyxoviruses for cancer therapy.Measles Edmonston vaccine strain derivatives have potent oncolytic activity against osteosarcoma.Analysis of the noncoding regions of measles virus strains in the Edmonston vaccine lineage.Toxicology study of repeat intracerebral administration of a measles virus derivative producing carcinoembryonic antigen in rhesus macaques in support of a phase I/II clinical trial for patients with recurrent gliomas.Measles vaccination policy.A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer.Measles antibody prevalence after mass immunization campaign in Niterói, state of Rio de Janeiro, Brazil.Changing epidemiology of measles in Africa.
P2860
Q24602003-B836A6C7-036D-4BED-9A5B-BB0137D231B2Q27485607-F126FEA4-3B0B-4F0A-B3BD-F1BADAC0F045Q28285300-C5620A10-0E3F-4287-91A9-490E3FCE2A81Q31142094-AF98BB20-7B68-486C-9460-61AD678F7911Q33789296-30B8DF37-DC9F-47FC-96CC-CB33FFF35A11Q33803714-6E63F730-88A7-41D8-B9BB-794C805E1108Q33815802-1ECE9F5F-D215-4B9F-8F84-9BC4ED10983FQ33835693-DAD4E5EC-9677-4EA9-B73E-9E11BB460B54Q33932032-58FBDCBA-F65D-466B-A60C-DE3C0B409D07Q33965913-5DA0D5FA-6399-4978-9AC3-95BC69A9082AQ34432804-FF0E269F-67CA-40FD-862C-A9AE2EC30B21Q34554618-1E85D3F0-253E-4F8F-A995-49764BA68AA9Q35226511-353C1DC2-E241-4BBA-863B-50726F7C0B0FQ36099144-A1D2953E-65FC-4223-AF8D-C0C0A5149D5FQ36503906-CC1C3A0D-498B-4247-BADF-07AB88DBEBE7Q36663470-8883BA1E-9AC0-46C6-A053-89C808B63051Q36795545-7AFC7748-9AC9-4949-9EFB-B5DD303B67EEQ37137964-B314062A-00C3-48C2-B97F-1D38B54DF4F5Q37267180-EC90A905-85C1-4105-AAD1-88166196A2BDQ37280354-504F8A25-F00A-442F-9871-3958F599A472Q37332702-A27DFEB3-DE77-4E04-99B5-032980B79024Q37794772-F02F1354-8364-4C28-ACFC-8975B3BA5427Q37810599-14A0B619-10AB-4C1B-A466-FBFC29D4950AQ38940653-9E2E9D92-AF9A-4E19-8AE1-CC46F6552FB5Q39601579-DD641503-4055-4C6D-92F9-4F3932F6F027Q40416129-7D1DD894-B32D-4766-9984-E4E338C05D38Q40964995-916D8C47-4DA9-4B69-A0E5-C602BB29FFA2Q43666519-BE5E3718-FD5B-4C68-8F30-34182FAC42AEQ45199895-0F71A75E-F636-4612-8AE6-B13CD0DDE063Q46236301-C6BC5D62-5489-4612-BC64-16B48D1CC9E6
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Successes and failures in measles control.
@en
type
label
Successes and failures in measles control.
@en
prefLabel
Successes and failures in measles control.
@en
P1476
Successes and failures in measles control.
@en
P2093
Markowitz LE
P304
P356
10.1093/INFDIS/170.SUPPLEMENT_1.S32
P407
P478
170 Suppl 1
P577
1994-11-01T00:00:00Z